Beverly Wolgast, PhD
Dr. Wolgast received her PhD in Synthetic Organic Chemistry from Brandeis and her postdoc from Harvard. With over 30 years of experience in pharma and biotech, she has worked at Arena, Celgene, Takeda, and Novartis, assuming leadership roles at each company.
Robert Arnold Jr.
VP of Business Development
Mr. Arnold executive leadership roles span over 30 years. His success in sales, eCommerce, retention, and affiliate & alliance marketing have been recognized in the security, casino/resort, and high-end construction consulting industries.
Mr. Ballard graduated from Duke with a BS in accounting. He held senior executive positions in several of the world’s largest commercial real estate firms. Most recently, he started the financial and accounting divisions for IndCor Properties, Inc.
Mr. Kirk graduated from Stanford with a BS in Economics. He has been investing in venture capital and real estate for over 30 years. His investments span energy, tech companies, consumer goods, private operating companies, VC funds, and biotech. Mr. Kirk is currently the largest stockholder.
Mr. DeFrank is currently President and CFO of Active Motif. He led the acquisitions and subsequent integrations of LP Bio, GenPathway, and SwitchGear Genomics. He has also served as President and General Manager of Pierce Biotechnology, CEO of Assay Designs, and COO of Invitrogen.
Mr. Wasserman is a consultant and business advisor with extensive experience as a Senior Operating executive and CFO, driving global organizations to outperform expectations for revenue, profits, and growth. He has ample experience working in the medical device, diagnostic systems, and biopharma sectors.
Copyright ©2017 Diomics Corporation. All rights reserved.